Nessan Bermingham - 20 Nov 2020 Form 4/A - Amendment Insider Report for F-star Therapeutics, Inc.

Role
Director
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
20 Nov 2020
Net transactions value
$0
Form type
4/A - Amendment
Filing time
24 Aug 2021, 18:34:09 UTC
Date Of Original Report
24 Nov 2020
Next filing
07 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FSTX Common Stock Award $0 +16,875 $0.000000 16,875 20 Nov 2020 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment to the Form 4 filed on November 24, 2020 is being filed solely to report the ownership of the restricted stock units ("RSUs") received by the Reporting Person in Table I of this Form 4 rather than in Table II as originally reported. No additional grants of securities are reported hereby.
F2 The securities awarded are in the form of RSUs. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five per cent (25%) of the total number of shares under the award shall vest on the first anniversary of the "Vesting Commencement Date," July 1, 2020, and two and one twelfth per cent (2.083%) of the total number of shares under the award shall vest monthly thereafter, provided in each case that the Reporting Person remains a service provider of the Issuer continuously from the Vesting Commencement Date to the relevant date.